| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 208,131 | 217,984 | 230,992 | 241,753 | | Cost of Revenue | 147,835 | 155,440 | 162,562 | 167,256 | | | Gross Profit | 60,296 | 62,544 | 68,430 | 74,497 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 50,450 | 55,255 | 53,980 | 54,989 | | Non Recurring |
-
|
-
| 126,719 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,846 | 7,289 | (112,269) | 19,508 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,846 | 7,289 | (112,269) | 19,508 | | Interest Expense | 3,711 | 3,315 | 3,263 | 3,821 | | Income Before Tax | 6,135 | 3,974 | (115,532) | 15,687 | | Income Tax Expense | 2,867 | 1,131 | (29,229) | 6,149 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,268 | 2,843 | (86,303) | 9,538 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,268 | 2,843 | (86,303) | 9,538 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,268 | $2,843 | ($86,303) | $9,538 |
|
0.51% Nasdaq 
Income Statement
